Papers: 10.1186/s13063-021-05373-8

https://doi.org/10.1186/s13063-021-05373-8

SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia—a phase II randomised control trial study protocol

Cited by: 4
Author(s): Caroline McCarthy, Joseph J. Sacco, Stefano Fedele, Michael Ho, Stephen Porter, Triantafillos Liloglou, Bill Greenhalf, Max Robinson, Bridget Young, Silvia Cicconi, Seema Chauhan, Binyam Tesfaye, Richard A. Jackson, Frances C Sherratt, Richard Shaw
Published: about 4 years ago

Software Mentions 1